- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT02951143
Abuse Liability of Reduced Nicotine Content Cigarettes Within a Complex Tobacco Marketplace
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The specific objective in Experiment 1 is to examine the effect of nicotine content (0.4 mg/g, 1.4 mg/g, 2.5 mg/g, 5.6 mg/g, and 17.4 mg/g of tobacco) and blood nicotine absorption on laboratory behavioral economic measures of demand intensity and elasticity. Under double-blind conditions, we will examine the relationship between plasma nicotine and cigarette demand as a function of the dose of the nicotine in the cigarettes. Regular cigarette smokers will consume, on separate sessions, controlled puffs of a cigarette containing a blinded dose of nicotine then complete a cigarette purchase task, our measure of value, while plasma nicotine is measured. We hypothesize that cigarette demand will be associated with dose and level of circulating nicotine, but in a nonlinear fashion such that consumption of very low dose cigarettes will not be predicted by nicotine dose or intake alone.
To inform how various products may interact, we have developed and tested a novel method called the Experimental Tobacco Marketplace. The Experimental Tobacco Marketplace is a systematic extension of similar marketplace methods used with other consumer products (e.g., food marketplaces used in obesity and other nutrition-related research; Epstein, Dearing, Roba, & Finkelstein, 2010). In experimental marketplaces, multiple products are available and the experimenter controls the prices for each. These marketplaces can be either physical or virtual stores (similar to online retailers) and permit the examination of demand elasticity and intensity and degree of substitution or complementarity in consumer behavior under conditions that approximate naturalistic settings.
Experiment 2 will extend findings from the first experiment examining the effects of different concentrations of nicotine in cigarettes (0.4mg/g, 1.4mg/g, 2.5mg/g, 5.6mg/g, 17.4mg/g) and blood nictotine absorption on laboratory behavioral economic demand measures. Employing this innovative Experimental Tobacco Marketplace, we propose to examine reduced-nicotine cigarettes under the following conditions: 1) control conditions where lower dose nicotine cigarettes are the only available product in the Experimental Tobacco Marketplace and where the tobacco marketplace is similar to the current real-world marketplace (i.e., no lower dose nicotine cigarettes, but a variety of other tobacco products); 2) lower dose nicotine cigarettes are available with a number of other nicotine products excluding conventional cigarettes; and 3) lower dose nicotine cigarettes are available with a number of other nicotine products including conventional cigarettes.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Virginia
-
Roanoke, Virginia, Estados Unidos, 24016
- Fralin Biomedical Research Institute at VTC
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- smoke at least 5 cigarettes per day
- have a breath carbon monoxide (CO) level of at least 10 ppm at intake
- no immediate plans to quit smoking.
Exclusion Criteria:
- pregnant, lactating, plans to become pregnant
- weigh more than 110lbs (experiment 1 only)
- have plans to move out of the area during the course of the experiment
To see if you are eligible, use the following confidential link: http://vtcri.info/arrcclinicaltrials
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Ciência básica
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Experimental: Single arm
All participants will complete the same experimental events across 6 laboratory sessions.
|
Across six laboratory sessions, participants will consume 10 puffs of either their usual brand of cigarette (one session) or a SPECTRUM cigarette (five sessions) with a nicotine yield varying from 0.03 to 0.70 and either menthol (TPMF codes NRC 103, NRC 201, NRC 301, NRC 401, and NRC 601) or tobacco (TPMF codes NRC 102, NRC 200, NRC 300, NRC 400, and NRC 600) flavor, depending on preference.
This will be followed by the collection of blood nicotine content and a cigarette purchase task.
|
Experimental: 0.4 mg/g Concentration
Participants in this arm will experience the 0.4 mg/g Concentration
|
Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette.
They will complete a cigarette purchase task and make real purchases for the next week.
Participants will return and make purchases again, repeating 4 times.
|
Experimental: 1.3 mg/g Concentration
Participants in this arm will experience the 1.3 mg/g Concentration
|
Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette.
They will complete a cigarette purchase task and make real purchases for the next week.
Participants will return and make purchases again, repeating 4 times.
|
Experimental: 2.4 mg/g Concentration
Participants in this arm will experience the 2.4 mg/g Concentration
|
Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette.
They will complete a cigarette purchase task and make real purchases for the next week.
Participants will return and make purchases again, repeating 4 times.
|
Experimental: 5.2 mg/g Concentration
Participants in this arm will experience the 5.2 mg/g Concentration
|
Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette.
They will complete a cigarette purchase task and make real purchases for the next week.
Participants will return and make purchases again, repeating 4 times.
|
Experimental: 15.8 mg/g Concentration
Participants in this arm will experience the 15.8 mg/g Concentration
|
Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette.
They will complete a cigarette purchase task and make real purchases for the next week.
Participants will return and make purchases again, repeating 4 times.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Estimated Cigarettes Taken at Free Price Derived From the Cigarette Purchase Task
Prazo: 10 minutes after cigarette administration
|
The Cigarette Purchase Task is a behavioral economic measure of abuse liability that consists of a series of hypothetical questions asking participants to indicate how many cigarettes they would purchase for their own consumption across a range of cigarette prices.
Participants smoked one cigarette and then were asked to report how many cigarettes they would smoke within a 24 hour period at the following prices: $0.00 (free), $0.01, $0.05, $0.10, $0.25, $0.50, $1, $2, $5, $10, $25, $50, $100, $200.
Nonlinear regression was then used to estimate the number of cigarettes participants would take when they were free using the equation by Koffarnus et al. (2015; doi:10.1037/pha0000045).
The outcome is the logarithmically transformed number of cigarettes.
|
10 minutes after cigarette administration
|
Change in Blood Nicotine Content Over the Course of the Session
Prazo: Each session (6 sessions total) with at least 2 days between each session.
|
For participants in the single arm only, blood will be collected throughout each session and analyzed for nicotine content.
The change in blood nicotine content over the course of the session will be compared among the six sessions where different cigarettes were administered.
Blood nicotine (expressed in ng/mL) at minute 0 was subtracted from blood nicotine at minutes 10, 15, 20, 30, 45, and 60 to yield a change in blood nicotine (negative values were truncated to 0) at each of the time points.
Using these change in blood nicotine values, we calculated Area Under the Curve (AUC) via the trapezoidal rule, which resulted in a singular number (total change in blood nicotine over the course of each experimental session) in our primary outcome measure.
|
Each session (6 sessions total) with at least 2 days between each session.
|
Experimental Marketplace Purchases
Prazo: Sessions 2-5 with each session conducted one week apart (for 4 weeks total)
|
In all arms except the single arm, measures of quantities of experimental cigarettes and other nicotine products will be obtained.
|
Sessions 2-5 with each session conducted one week apart (for 4 weeks total)
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Warren K Bickel, PhD, Virginia Polytechnic Institute and State University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- R01DA042535 (Concessão/Contrato do NIH dos EUA)
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em SPECTRUM cigarettes
-
University of New MexicoNational Institute of Mental Health (NIMH); University of Texas; The Mind Research...ConcluídoTranstorno Depressivo MaiorEstados Unidos
-
Duke UniversityNational Institute on Drug Abuse (NIDA)Ativo, não recrutandoDor crônica | Fumar, cigarroEstados Unidos
-
Justice Resource InstituteConcluídoTranstorno de Estresse Pós-TraumáticoEstados Unidos
-
Haukeland University HospitalUniversity of Bergen; Norwegian University of Science and Technology; St. Olavs... e outros colaboradoresRecrutamentoTranstorno do Espectro AutistaNoruega
-
Singapore National Eye CentreNational University, Singapore; Singapore Eye Research InstituteConcluídoDisfunção da Glândula MeibomianaCingapura
-
Main Line HealthAnanda Hemp, Inc.Ativo, não recrutandoCâncer de mama | Câncer de pâncreas | Cancro do ovário | Câncer Colorretal Estágio II | Câncer Colorretal Estágio III | Neuropatia periférica induzida por quimioterapia | Câncer uterinoEstados Unidos
-
Formula30A LLCConcluídoDistúrbio de ansiedade generalizadaEstados Unidos, Porto Rico
-
University of New MexicoNational Institute of Mental Health (NIMH); University of Texas Southwestern... e outros colaboradoresConcluído
-
Wake Forest University Health SciencesRecrutamentoUso do tabacoEstados Unidos
-
Finch Research and Development LLC.Medpace, Inc.ConcluídoInfecção por Clostridium Difficile | Infecção Recorrente por Clostridium Difficile | C. Diferença | CDI | Recorrente C. Dif | rCDI | C. difícil | CDI recorrente | FMT | Microbiota Fecal | Transplante FecalEstados Unidos, Canadá